Teva

Teva
255px
Tipo	Compañía Pública (NASDAQ: TEVA)
Fundación	1901
Sede	Petah Tikva (Israel)
Industria	Farmacéutica
Productos	Fármacos
Ingresos	$11.080 billones USD (FY 2008)
Beneficio neto	$2.374 billones USD (FY 2008)
Empleados	28,000 (2007)

Teva Pharmaceutical Industries Ltd. (en hebreo: טבע תעשיות פרמצבטיות בע"מ‎), NASDAQ: TEVA es una compañía farmacéutica internacional cuya sede central se encuentra en Petah Tikva, Israel. Se especializa en drogas genéricas e ingredientes activos. Es la mayor manufacturera de drogas genéricas en el mundo y una de las 20 compañías farmacéuticas más grandes del mundo.^[1] En el año 2007 sus ventas supusieron un total de 9.400 millones de dólares, el 80% en Europa y América del Norte. Después de su adquisición de la empresea rival estadounidense Ivax Corporation en enero de 2006, Teva alcanzó los 28.000 empleados distribuidos en 50 países. Sus instalaciones se encuentran en Israel, América del Norte, Europa y Latinoamérica. Teva es en la actualidad la novena empresa por capitalización de mercado según el Nasdaq, por detrás de Gilead (febrero de 2009).

Historia

Teva's earliest predecessor was Salomon, Levin, and Elstein Ltd., a wholesale distributor based in Jerusalem that was founded in 1901. During the 1930s, new immigrants from Europe founded several pharmaceutical companies including Teva, Assia, and Zori. In 1951, Teva raised capital through the newly founded Tel-Aviv Stock Exchange.

In 1964, Assia and Zori merged and acquired a controlling interest in Teva. In 1976, these three companies merged into the modern Teva Pharmaceutical Industries Ltd. In 1980, Teva continued to follow its vision of becoming one of the world's biggest Pharmaceutical companies by acquiring Ikapharm, then Israel's second largest drug manufacturer. ^[2]

In 1982, Teva was granted FDA approval for its Kfar Sava manufacturing plant, an essential milestone for marketing pharmaceuticals in the USA.

Teva's Innovative Research and Development has been granted approval for two innovative drugs: Copaxone (for the treatment of multiple sclerosis) in the mid-1990s, and Azilect (sold as Agilect in some countries) for treatment of Parkinson's disease in the 2000s. Several innovative compounds are in the pipeline, but the innovative arm carries far less weight in Teva (when compared to generics) than in any other top 20 pharmaceutical company.^{[cita requerida]}

On June 23, 2006, Teva (through a former Ivax subsidiary) received from the U.S. Food & Drug Administration a 180-day exclusivity period to sell simvastatin (Zocor) in the U.S. as a generic drug in all strengths except 80 mg. Teva presently competes with the maker of brand-name Zocor, Merck & Co.; Ranbaxy Laboratories, which has 180-day exclusivity for the 80 mg strength; and Dr. Reddy's Laboratories, whose authorized generic version (licensed by Merck) is exempt from exclusivity.

In 2005, Teva opened a new, state-of-the-art pharmaceutical manufacturing plant in Har Hotzvim, a technology park in Jerusalem. The plant received FDA approval in early 2007.

On December 24, 2007, Teva released an AB-rated generic alternative to Protonix.^[3]

On December 23, 2008, Teva acquired Barr Pharmaceuticals for 7.5 billion USD, making Barr and Pliva (which Barr bought earlier) part of Teva.^[4]

Products

Pharmaceuticals

• Copaxone
• Laquinimod
• Rasagiline
• Venlafaxine

Subsidiarios

• North America
  • Barr Pharmaceuticals
  • Teva Pharmaceuticals USA
  • Plantex USA
  • Teva Parenteral Medicines
  • Teva Specialty Pharmaceuticals
  • Teva Biopharmaceuticals USA
  • Teva Neuroscience
  • Teva Neuroscience Canada
  • Teva Novopharm
  • Teva Animal Health
• Latin America
  • Teva Pharmaceuticals Curaçao N.V.
  • Teva Mexico
  • Ivax Argentina
  • Laboratorio Chile sitio web
  • Teva Brazil
  • Corporacion Medco - Peru
  • Corporacion Infarmasa - Peru
• Europe
  • Pliva Croatia
  • Teva Pharmaceuticals Europe B.V.
  • Teva Pharmachemie B.V.
  • Plantex Chemicals B.V.
  • Teva Pharma UK
  • Teva UK Limited
  • Teva Pharmaceuticals Ireland
  • Teva Pharmaceutical Works Ltd.
  • Teva Hungary Ltd.
  • Teva Classics France
  • Teva Group Germany
  • Teva Pharma Italia S.r.I.
  • Teva Pharmaceutical Fine Chemicals S.r.I.
  • Sicor Italy S.r.I.
  • Prosintex - ICI
  • Teva Belgium
  • Sicor Biotech UAB
  • Teva Pharmaceuticals CR, s.r.o.
  • Teva Pharmaceuticals Slovakia, s.r.o.
  • Teva Pharma AG
  • Sicor Europe
  • Teva Sweden AB
  • Teva Finland Oy
  • Teva API International Spain
  • Teva Genericos España sitio web
  • Teva Pharma Portugal Ltd.
  • Teva Bulgaria
  • Teva Moscow
  • Teva Belarus
  • Teva Ukraine
  • Teva Kazakhstan
  • Teva Pharmaceuticals Polska (Poland)
• Asia
  • Teva Singapore
  • Teva Japan
  • Teva API India Ltd.
• Africa
  • Assia Pharmaceuticals Ltd.
  • Teva Pharmaceuticals (Pty) Ltd.

Animal rights arrests

Two Israeli animal rights activists and a photographer were charged with "illegal gathering" in Petah-Tikva, Israel, after being arrested in December 2006 for holding a vigil outside TEVA's offices. The activists were protesting because TEVA is a client of Huntingdon Life Sciences (HLS), which is the focus of an international animal rights campaign, Stop Huntingdon Animal Cruelty.^[5]

References

• Pharmaceutical Executive (PDF)

See also

• Qualitest

Enlaces externos

• Corporate website

Plantilla:Companies portal Plantilla:NASDAQ-100